Beam Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $647.7M | $1.47B | $560.0M |
| FY2022 | $608.2M | $1.34B | $232.8M |
| FY2023 | $478.4M | $1.46B | $435.9M |
| FY2024 | $370.3M | $1.10B | $282.0M |
| FY2025 | $242.8M | $1.48B | $294.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $647.7M | $1.47B | $560.0M |
| FY2022 | $608.2M | $1.34B | $232.8M |
| FY2023 | $478.4M | $1.46B | $435.9M |
| FY2024 | $370.3M | $1.10B | $282.0M |
| FY2025 | $242.8M | $1.48B | $294.9M |